Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (6352)	4/11/1999 10:56:00 AM
From: BDR	Read Replies (1) \| Respond to of 7041

Well, if SI ever gets its server fixed, that link should show you the number of papers being presented at the AUA this year that focus on various impotence treatments. I could find none listed for Vasomax. Odd given the fact that it has been on the market in Mexico for some time and I would have thought that, if it was so effective, that there would be some early reports from practitioners about their real world experiences with the drug by now. As I recall there was a paper presented last year (by Goldstein?) on Vasomax and the results were so unimpressive that the stock dropped afterward. There may be surprises from the AUA but they shouldn't be on the upside as far as the stock price is concerned.